Background/Objectives: Sarcomas are a rare and heterogeneous group of malignant tumors, which makes early detection and grading particularly challenging. Diagnosis traditionally relies on expert visual interpretation of histopathological biopsies and radiological imaging, processes that can be time-consuming, subjective and susceptible to inter-observer variability. Methods: In this study, we aim to explore the potential of artificial intelligence (AI), specifically radiomics and machine learning (ML), to support sarcoma diagnosis and grading based on MRI scans. We extracted quantitative features from both raw and wavelet-transformed images, including first-order statistics and texture descriptors such as the gray-level co-occurrence matrix (GLCM), gray-level size-zone matrix (GLSZM), gray-level run-length matrix (GLRLM), and neighboring gray tone difference matrix (NGTDM). These features were used to train ML models for two tasks: binary classification of healthy vs. pathological tissue and prognostic grading of sarcomas based on the French FNCLCC system. Results: The binary classification achieved an accuracy of 76.02% using a combination of features from both raw and transformed images. FNCLCC grade classification reached an accuracy of 57.6% under the same conditions. Specifically, wavelet transforms of raw images boosted classification accuracy, hinting at the large potential that image transforms can add to these tasks. Conclusions: Our findings highlight the value of combining multiple radiomic features and demonstrate that wavelet transforms significantly enhance classification performance. By outlining the potential of AI-based approaches in sarcoma diagnostics, this work seeks to promote the development of decision support systems that could assist clinicians.

Retinal diseases are among the leading causes of vision impairment worldwide, and early detection is essential for enabling personalized treatments and preventing irreversible vision loss. In this paper, we propose a method aimed to identify and localize retinal conditions, i.e., Age-Related Macular Degeneration, Diabetic Retinopathy, and Choroidal Neovascularization, using explainable deep learning. For this purpose, we consider seven fine-tuned convolutional neural networks: MobileNet, LeNet, StandardCNN, CustomCNN, DenseNet, Inception, and EfficientNet. Moreover, we develop a novel architecture i.e., NeoNet, specifically designed for the detection of retinal diseases, achieving an accuracy of 99.5%. Furthermore, with the aim to provide explaianability behind the model decision, we highlight the most critical regions within retinal images influencing the predictions of the model. The obtained results show the ability of the model to detect pathological features, thereby supporting earlier and more accurate diagnosis of retinal diseases.

Diabetic retinopathy represents one of the leading causes of blindness worldwide, making early diagnosis essential for effective clinical intervention. We propose an explainable method aimed at automatically identifying the severity levels of diabetic retinopathy in retinal images using deep learning. The proposed method considers several convolutional neural network architectures, i.e., VGG16, StandardCNN, ResNet, CustomCNN, EfficientNet, MobileNet, and a novel architecture, i.e., FGNet, specifically designed and developed by the authors for diabetic retinopathy detection. The proposed network achieves an accuracy of 0.75 when trained for 10 epochs and 0.71 for 20 epochs. Explainability behind model prediction is further supported through Gradient-weighted Class Activation Mapping, providing visual insight into the learned decision-making process and potentially supporting early clinical assessment.

Objective: This study introduces an explainable, radiomics-based machine learning framework for the automated classification of sarcoma tumors using MRI. The approach aims to empower clinicians, reducing dependence on subjective image interpretation. Methods: A total of 186 MRI scans from 86 patients diagnosed with bone and soft tissue sarcoma were manually segmented to isolate tumor regions and corresponding healthy tissue. From these segmentations, 851 handcrafted radiomic features were extracted, including wavelet-transformed descriptors. A Random Forest classifier was trained to distinguish between tumor and healthy tissue, with hyperparameter tuning performed through nested cross-validation. To ensure transparency and interpretability, model behavior was explored through Feature Importance analysis and Local Interpretable Model-agnostic Explanations (LIME). Results: The model achieved an F1-score of 0.742, with an accuracy of 0.724 on the test set. LIME analysis revealed that texture and wavelet-based features were the most influential in driving the model’s predictions. Conclusions: By enabling accurate and interpretable classification of sarcomas in MRI, the proposed method provides a non-invasive approach to tumor classification, supporting an earlier, more personalized and precision-driven diagnosis. This study highlights the potential of explainable AI to assist in more secure clinical decision-making.